CMS plans to write a rule to limit price concessions that pharmacy benefit managers retroactively charge pharmacies, according to a letter from Administrator Chiquita Brooks-LaSure in response to concerns by Senate Finance Chair Ron Wyden that the PBM fees are driving up drug costs and running pharmacies out of business. Drug makers complain that PBMs are getting a pass in the drug pricing title of Build Back Better legislation, but the Oregon Democrat gave no indication Thursday (Dec. 16) that...